Web5 uur geleden · Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, ... Sherri Spear Merus N.V. VP Investor Relations and Corporate Communications 617-821-3246 [email protected] Kathleen Farren Merus N.V. IR/Corp Comms 617-230-4165 [email protected]. WebAt Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer. Utilizing our proprietary technology …

Merus N.V. LinkedIn

WebBefore joining Merus in 2009, Dr. Geuijen worked as a senior scientist on the evaluation of new therapeutic targets in oncology at Genmab and the identification of new … WebWe are a fast-growing, international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. Our Products We are focused on our vision of transforming the future of cancer treatment. Explore our products Investors pearson institute prospectus 2022

Werken bij Merus N.V. Vacatures Magnet.me (nl)

WebDescription. Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human … WebMerus is a clinical stage biotechnology company based in Utrecht, The Netherlands, that develops innovative therapeutics to address serious unmet needs in oncology. At … Web14 apr. 2024 · Delivery and takeaway sales continue to drop, CGA reports. Combined sales of delivery and takeaway food declined by 6% in February 2024 compared to the same period last year. In de UK rond 6% en Nederland ook zoiets. Het moet in de rest van de gebieden dan wel erg slecht gaan om op een gemiddelde van 15% te komen. pearson institute of higher learning